首页> 外文期刊>Journal of Materials Chemistry, B. materials for biology and medicine >Highly stable intrinsically radiolabeled indium-Ill quantum dots with multidentate zwitterionic surface coating: dual modality tool for biological imaging
【24h】

Highly stable intrinsically radiolabeled indium-Ill quantum dots with multidentate zwitterionic surface coating: dual modality tool for biological imaging

机译:具有多齿两性离子表面涂层的高度稳定的本征放射性标记的铟-quantum量子点:用于生物成像的双模式工具

获取原文
获取原文并翻译 | 示例
           

摘要

Here we describe a novel strategy to incorporate indium-Ill into near infrared (NIR) emitting Cu-ln-Se quantum dots (CIS-QDs) to synthesize intrinsically radiolabeled QDs (rQDs), as a quantitative tool for in vivo SPECT/fluorescence imaging. Multidentate zwitterionic polymer ligands were used to functionalize and improve the stability of CIS-rQDs and reduce nonspecific binding with plasma proteins/cetl membrane. CIS-rQDs were taken up by colorectal adenocarcinoma (COLO-205) and human epidermoid carcinoma (KB-3-1) cells at low uptake rate (~0.4%, 2 x 105 QDs per cell at 24 h) and reduced nonspecific interaction of zwitterionic CIS-rQDs with cells was observed by fluorescence microscopy. The cytotoxicity of CIS-rQDs was reduced due to the low toxic inorganic composition of QDs and multidentate zwitterionic surface coating. In 5 out of 6 nude mice bearing either COLO-205 or KB-3-1 tumor, both SPECT and fluorescence imaging demonstrated passive localization of CIS-rQDs in the tumor as early as 6 h post-injection. In these mice the passive accumulation of CIS-rQDs in the tumor, due to leaky vasculature, ranged from ~0.3% ID per g to ~4.6% ID per g at 48 h post-injection (from region of interest analysis of SPECT imaging). This intrinsic radio-labeling strategy provides a nanoparticle platform which incorporates imaging and potentially therapeutic radionuclides with retention of fluorescence intensity. It also provides complimentary quantitative data capabilities for both in vivo SPECT imaging and radiotracer ex vivo analysis.
机译:在这里,我们描述了一种新颖的策略,可将铟-III掺入发射近红外(NIR)的Cu-In-Se量子点(CIS-QDs)中,以合成固有放射性标记的QD(rQDs),作为体内SPECT /荧光成像的定量工具。多齿两性离子聚合物配体用于功能化和改善CIS-rQD的稳定性,并减少与血浆蛋白/细胞膜的非特异性结合。 CIS-rQDs被大肠腺癌(COLO-205)和人表皮样癌(KB-3-1)细胞摄取,吸收率低(〜0.4%,24小时每个细胞2 x 105 QDs),并降低了非特异性相互作用。通过荧光显微镜观察到两性离子与细胞的CIS-rQDs。由于QDs的低毒性无机成分和多齿两性离子表面涂层,可降低CIS-rQDs的细胞毒性。在6只带有COLO-205或KB-3-1肿瘤的裸鼠中,有5只在注射后6 h内,SPECT和荧光成像均显示了CIS-rQD在肿瘤中的被动定位。在这些小鼠中,由于脉管系统渗漏,CIS-rQD在肿瘤中的被动积累在注射后48 h范围内为每克〜0.3%ID至每克〜4.6%ID(来自SPECT成像的目标区域) 。这种固有的放射性标记策略提供了一个纳米粒子平台,该平台结合了成像和潜在的治疗性放射性核素,并保留了荧光强度。它还为体内SPECT成像和放射性示踪剂离体分析提供了互补的定量数据功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号